Longevity Diagnostics, Preventive Health & Epigenetic Therapies: What Patients and Families Should Know Now
A free live roundtable on biomarkers, epigenetics, personalized medicine and prevention — featuring Manuel Serrano and moderated by Adam Satir.
Molecular biologist specializing in cellular senescence, reprogramming and the biology of aging.
Educational event only. No medical advice, no diagnostic claims, no hype — just a serious conversation about longevity diagnostics, prevention, biomarkers, epigenetics and personalized medicine.
Why This Conversation Matters
Longevity is moving from a general wellness idea toward a more practical conversation about biomarkers, biological aging, epigenetics, personalized medicine and prevention. This roundtable explores what is promising, what is still emerging and what patients and families should understand before making decisions.
Biomarkers and diagnostics
Understand how biomarkers may help describe health risks, track biological processes and support more informed preventive care.
Epigenetics and aging biology
Explore how epigenetics, cellular senescence and reprogramming research are changing the way scientists think about aging.
Personalized prevention
Discuss how personalized medicine may support prevention while keeping expectations grounded in evidence and clinical context.
Meet the Speakers
Expert perspectives on biomarkers, epigenetics, personalized medicine, prevention and the science of healthy longevity — with additional speakers to be announced.
Manuel Serrano
Manuel Serrano Marugán specializes in biomolecular research, particularly cellular senescence and reprogramming. He currently works at Altos Labs, a biotechnology company backed with $3 billion in funding from Jeff Bezos. Serrano is the author of articles in leading scientific journals including Nature, Cell, Science and others, and co-authored the landmark longevity paper “The Hallmarks of Aging.”
Adam Satir
Founder and CEO of DynaSpan Global, a media and events company focused on healthy aging through technology.
Speaker to be announced
Additional expert speaker to be confirmed. This session will bring together clinical, research and technology perspectives on biomarkers, diagnostics and prevention.
Speaker to be announced
Additional expert speaker to be confirmed. The discussion will include responsible perspectives on epigenetics, personalized medicine, prevention and the future of healthy longevity.
What We’ll Cover
Opening: why longevity diagnostics and prevention belong in the same conversation
Biomarkers, biological age and what today’s tests can and cannot tell us
Cellular senescence, epigenetics, reprogramming and longevity research
Personalized prevention: practical possibilities, limitations and risks
Live Q&A with audience questions
Who Should Attend?
Patients and families
Anyone interested in preventive health, longevity diagnostics, biomarkers or how to make better-informed health decisions.
Clinicians and researchers
Professionals interested in aging biology, biomarkers, diagnostics, epigenetics, prevention and patient education.
Healthy aging communities
People interested in longevity, prevention, personalized medicine, biological age and the future of evidence-based healthy aging.
Questions We May Ask
What are biomarkers, and how can they support preventive health?
The discussion will explore how biomarkers may help describe health risks and aging-related processes, while avoiding overpromising or replacing clinical judgment.
Can biological age or epigenetic testing guide personal health decisions?
We will discuss what biological age and epigenetic clocks may suggest, what remains uncertain, and why clinical validation and context matter.
What is Personalized prevention, and what can it realistically do?
The conversation will cover the scientific promise of epigenetics, cellular reprogramming and related approaches, while separating established care from emerging research.
How should patients and families think about personalized medicine without hype?
The goal is to help people separate established prevention strategies from emerging diagnostics and therapies, and ask clearer questions about evidence, safety and clinical relevance.
Is this event medical advice?
No. This is an educational discussion. Patients should always speak with their own qualified healthcare professional before making medical decisions.
Reserve Your Free Spot
Join a serious, accessible conversation on longevity diagnostics, preventive health, biomarkers, epigenetics, personalized medicine and prevention.
Register Free